Stay updated with breaking news from Gerhard Dahlhoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- OncoBeta® GmbH, a medical device company specialised in innovative epidermal radioisotope therapies, has confirmed the phase IV international...
/PRNewswire/ -- OncoBeta® GmbH has announced University Clinic of Rostock is participating in the global phase IV EPIC-Skin Study (Efficacy of Personalised...
/PRNewswire/ -- OncoBeta® GmbH today announces the first Austrian patients have been treated in the global phase IV EPIC-Skin Study (Efficacy of Personalised...
/PRNewswire/ -- OncoBeta® GmbH today announces the first Austrian patients have been treated in the global phase IV EPIC-Skin Study (Efficacy of Personalised...
/PRNewswire/ -- OncoBeta® GmbH has today announced a world-first from Australia, with the first patients treated with Rhenium-SCT® as part of the global phase...